MMN clinical trials at UCSF

1 research study open to eligible people

Empasiprubart Versus IVIg in Adults With Multifocal Motor Neuropathy
open to eligible people ages 18 years and up
The main purpose of this study is to compare empasiprubart and IVIg in adult patients with MMN. The study consists of a double-blinded part A (empasiprubart, IVIg) and an open-label part B (empasiprubart). The maximum study duration for participants is up to 49 months.
San Francisco 5391959, California 5332921 and other locations

Last updated: October 16, 2025